Amgen

GPTKB entity

Properties (61)
Predicate Object
gptkbp:instanceOf biotechnology company
gptkbp:acquisition gptkb:Immunex_Corporation
Micromet
BLADE Therapeutics
Tularik
gptkbp:advertising gptkb:Lori_A._McCauley
gptkb:Gina_A._McCarthy
gptkbp:awards Best Places to Work
Fortune 500 company
World's_Most_Admired_Companies
gptkbp:CEO gptkb:Robert_A._Bradway
gptkb:Gina_A._McCarthy
gptkbp:clinicalTrials partnerships with hospitals
collaborations with academic institutions
Phase 3 trials for various drugs
global clinical trial networks
gptkbp:community gptkb:Gina_A._McCarthy
gptkbp:community_engagement STEM education initiatives
healthcare_access_programs
gptkbp:customerService gptkb:David_A._H._Hwang
gptkb:Gina_A._McCarthy
gptkbp:developer gptkb:Gina_A._McCarthy
gptkbp:employees approximately 24,000
gptkbp:founded 1980
gptkbp:founder gptkb:George_Rathmann
gptkbp:globalPresence gptkb:Murdo_Gordon
gptkbp:headquarters gptkb:Thousand_Oaks,_California
https://www.w3.org/2000/01/rdf-schema#label Amgen
gptkbp:industry Biotechnology
gptkbp:manager gptkb:Gina_A._McCarthy
gptkbp:market approximately $130 billion (2023)
gptkbp:operations gptkb:Gina_A._McCarthy
gptkbp:partnerships gptkb:AstraZeneca
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
Novartis
gptkbp:philanthropy gptkb:Amgen_Foundation
gptkbp:products gptkb:Enbrel
gptkb:Neulasta
Prolia
Repatha
gptkbp:regulates gptkb:Gina_A._McCarthy
gptkbp:regulatoryCompliance gptkb:Ruth_A._McCarty
gptkb:Robert_A._Bradway
gptkb:Gina_A._McCarthy
gptkbp:research gptkb:David_M._Reese
gptkb:Gina_A._McCarthy
gptkbp:research_focus oncology
inflammation
bone health
cardiovascular disease
gptkbp:revenue $25.42 billion (2022)
gptkbp:social_responsibility gptkb:Gina_A._McCarthy
gptkbp:stockExchange gptkb:NASDAQ
gptkb:AMGN
gptkbp:subsidiary gptkb:Onyx_Pharmaceuticals
KAI_Pharmaceuticals
gptkbp:supplyChain gptkb:Gina_A._McCarthy
gptkbp:sustainability_initiatives sustainability programs
carbon footprint reduction
gptkbp:tactics gptkb:Gina_A._McCarthy